• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

0.5164 +0.1491 (+40.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sunshine Biopharma Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
What's going on in today's after hours session ↗
Today 17:00 EDT
Via Chartmill
Most active stocks in Thursday's session ↗
Today 14:00 EDT
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
Today 13:00 EDT
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Today 10:30 EDT
Via Chartmill
News headline image
Sunshine Biopharma Stock Rallies On Canadian Approval For Generic Amoxicillin ↗
Today 9:31 EDT
Sunshine Biopharma (NASDAQ: SBFM) shares are trading higher Thursday after securing Canadian regulatory approval for generic amoxicillin. 
Via Benzinga
Sunshine Biopharma Stock Powers Ahead Following Launch Of Generic Cholesterol-Lowering Drug By Canadian Unit ↗
October 16, 2025
Via Stocktwits
What's going on in today's pre-market session ↗
Today 8:30 EDT
Via Chartmill
News headline image
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin
Today 7:00 EDT
Via ACCESS Newswire
Top movers in Wednesday's session ↗
May 20, 2026
Via Chartmill
BioMedNewsBreaks — Sunshine Biopharma Inc. (NASDAQ: SBFM) Closes $6 Million Public Offering
May 20, 2026
Via Investor Brand Network
Stay updated with the stocks that are on the move in today's pre-market session. ↗
May 20, 2026
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
May 19, 2026
Via Chartmill
News headline image
Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering
May 19, 2026
Via ACCESS Newswire
News headline image
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
May 18, 2026
Via ACCESS Newswire
News headline image
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
April 06, 2026
Via ACCESS Newswire
News headline image
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
October 28, 2025
Via ACCESS Newswire
News headline image
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
October 28, 2025
Via ACCESS Newswire
News headline image
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
October 20, 2025
Via ACCESS Newswire
News headline image
Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening ↗
October 16, 2025
Shares of Sunshine Biopharma Inc. (NASDAQ: SBFM) are trading higher Thursday after the Florida-based pharmaceutical company announced the launch of a generic prescription drug. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
October 16, 2025
 
Via Benzinga
News headline image
Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
October 16, 2025
Via ACCESS Newswire
News headline image
Sunshine Biopharma Stock is 34% Higher Since September as Investors Reward Performance Combined with Innovation (NASDAQ: SBFM)
October 16, 2025
Via AB Newswire
News headline image
Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)
October 14, 2025
Via ACCESS Newswire
News headline image
Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)
October 14, 2025
Via ACCESS Newswire
News headline image
Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience
October 14, 2025
Via ACCESS Newswire
News headline image
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections
October 09, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
August 12, 2025
 
Via Benzinga
News headline image
Sunshine Biopharma Stock Soars After Launch Of First Biosimilar In $10B Canadian Market: Retail Bulls Charge In ↗
July 02, 2025
The company launched Niopeg, a biosimilar to Neulasta, designed to reduce the risk of infection in chemotherapy patients. 
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
July 02, 2025
 
Via Benzinga
News headline image
Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market
July 02, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap